BIOCON Biocon Ltd Product Launches Announcement 2025 - FDA Approval Granted Biocon Pharma Limited has received US FDA approval for Rivaroxaban Tablets USP (2.5 mg, 10 mg, 15 mg, 20 mg), enhancing their drug portfolio..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Biocon Ltd